Ziad Obermeyer is in the Division of Health Policy and Management, School of Public Health, University of California, Berkeley, Berkeley, California 94720, USA. Read the paper: Efficient and targeted ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that its multimodal immune profile score (IPS) algorithmic test is ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that the company’s PurISTSM algorithmic test has received a ...

This is the third in a series of blog posts on MiFID II (Markets in Financial Instruments Directive II). If you missed the earlier posts, seeMiFID II: How Did We Get Here and What Does it ...

Tempus AI (TEM) announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. IPS, which is now available for clinicians to order, is a multimodal biomarker that can be used as a ...

British Journal of Sociology of Education, Vol. 38, No. 6 (September 2017), pp. 827-840 (14 pages) This article critically considers the promise of computer adaptive testing (CAT) and digital data to ...

A machine-learning algorithm could provide auto manufacturing, aerospace and other industries a faster and more cost-efficient way to test bulk materials. A machine-learning algorithm developed at ...